Empower Advisory Group
ABBV icon

Empower Advisory Group’s AbbVie ABBV Stock Holding History

Empower Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Sell
507,376
-7,218
-1% -$1.55M 0.3% 60
2026
Q1 		$112M Buy
514,594
+31,987
+7% +$7.1M 0.29% 71
2025
Q4 		$110M Sell
482,607
-21,661
-4% -$4.93M 0.3% 64
2025
Q3 		$117M Buy
504,268
+7,835
+2% +$1.6M 0.32% 59
2025
Q2 		$92.1M Buy
496,433
+22,390
+5% +$4.16M 0.28% 71
2025
Q1 		$99.3M Buy
474,043
+26,384
+6% +$5.13M 0.32% 57
2024
Q4 		$79.5M Buy
447,659
+12,415
+3% +$2.28M 0.27% 74
2024
Q3 		$86M Sell
435,244
-163,171
-27% -$30.5M 0.29% 74
2024
Q2 		$103M Sell
598,415
-9,270
-2% -$1.54M 0.38% 57
2024
Q1 		$111M Buy
607,685
+12,613
+2% +$2.17M 0.41% 50
2023
Q4 		$92.2M Buy
595,072
+19,856
+3% +$2.89M 0.36% 64
2023
Q3 		$85.7M Buy
575,216
+52,198
+10% +$7.66M 0.38% 53
2023
Q2 		$70.5M Buy
523,018
+38,914
+8% +$5.71M 0.3% 73
2023
Q1 		$77.7M Buy
+484,104
New +$74M 0.35% 66

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Empower Advisory Group's ABBV Position: Q2 2026 in Review

Empower Advisory Group reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $1.55M and leaving 507,376 shares worth $128M. The position accounts for 0.3% of the portfolio, ranked #60.

Empower Advisory Group first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Empower Advisory Group held 507,376 shares of AbbVie worth $128M as of Q2 2026.
  • Empower Advisory Group sold 7,218 AbbVie shares in Q2 2026, an estimated $1.55M.
  • AbbVie made up 0.3% of Empower Advisory Group's portfolio in Q2 2026, its #60 holding.
  • Empower Advisory Group first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.